Trial intelligence / Profile preview

EGP-437 Iontophoresis vs Prednisolone Acetate in Anterior Uveitis

NCT01505088Phase 3Completed

Sponsor
Kiora Pharmaceuticals
Start
Dec 2011
Primary completion
Feb 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dexamethasone phosphate iontophoretic ophthalmic solution in anterior uveitis (AU), sponsored by Kiora Pharmaceuticals. Started Dec 2011; status: completed.

02

Drugs

dexamethasone phosphate iontophoretic ophthalmic solution
03

Conditions

anterior uveitis (AU)

Beyond the preview

Go deeper on NCT01505088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01505088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call